Can a smart tool keep watch on leukemia after treatment stops?

NCT ID NCT07760311

Not yet recruiting Knowledge-focused Sponsor: Versailles Hospital Source: ClinicalTrials.gov ↗

First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time

Summary

This study explores whether a digital tool can help monitor adults with chronic myeloid leukemia who have stopped treatment for up to two years. Over 12 months, researchers will track how often patients use the tool, aiming for a usage rate of at least 60%. The goal is to see if this approach is practical for keeping an eye on patients' health without frequent clinic visits.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: A digital tool integrated into follow-up care for monitoring patients with chronic myeloid leukemia who have discontinued treatment.
What this could lead to: If successful, this could establish a practical way to monitor leukemia patients after stopping treatment, potentially improving care and reducing hospital visits.
What could go wrong: The study is small and early, focusing on feasibility rather than health outcomes. It may not prove that the tool improves patient health or is widely adoptable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic leukemia chronic myelogenous leukemia, BCR-ABL1 positive

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC LEUKEMIA

Contacts and locations

Locations

CH de Versailles

Le Chesnay, 78150, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.